ConductScience.org, home

Paper35239126

Bayesian penalized Buckley-James method for high dimensional bivariate censored regression models.

Yin W and 2 others. Lifetime Data Anal, 2022. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Bayesian penalized Buckley-James method for high dimensional bivariate censored regression models. Papers, record 35239126. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35239126

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Bayesian penalized Buckley-James method for high dimensional bivariate censored regression models.
PubMed
Journal
Lifetime Data Anal
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Relative citation ratio, by iCite
0
iCite
Revised in PubMed
2026-10-10
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yin WWenjing
2Zhao SDSihai Dave
3Liang FFenghttps://orcid.org/0000-0002-4173-3003

Source PubMed

Download CSV of authors

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AlgorithmsMajor topic
Bayes Theorem
Humans
Survival Analysis

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115293631Estimating marginal effects in accelerated failure time models for serial sojourn times among repeated events.Lifetime Data Anal2004https://conductscience.org/library/papers/15293631PubMed
215737088Quantile regression models with multivariate failure time data.Biometrics2005https://conductscience.org/library/papers/15737088PubMed
326445238PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma.J Hematol Oncol2015https://conductscience.org/library/papers/26445238PubMed
423475625Identification of an ABCB1 (P-glycoprotein)-positive carfilzomib-resistant myeloma subpopulation by the pluripotent stem cell fluorescent dye CDy1.Am J Hematol2013https://conductscience.org/library/papers/23475625PubMed
526243050A permutation approach for selecting the penalty parameter in penalized model selection.Biometrics2015https://conductscience.org/library/papers/26243050PubMed
616984324Regularized estimation in the accelerated failure time model with high-dimensional covariates.Biometrics2006https://conductscience.org/library/papers/16984324PubMed
724549607Marginal semiparametric multivariate accelerated failure time model with generalized estimating equations.Lifetime Data Anal2014https://conductscience.org/library/papers/24549607PubMed
831586968Stability selection for lasso, ridge and elastic net implemented with AFT models.Stat Appl Genet Mol Biol2019https://conductscience.org/library/papers/31586968PubMed
930400837Bayesian variable selection for parametric survival model with applications to cancer omics data.Hum Genomics2018https://conductscience.org/library/papers/30400837PubMed
1020013308Variable selection in the accelerated failure time model via the bridge method.Lifetime Data Anal2010https://conductscience.org/library/papers/20013308PubMed
1117221306Tests of independence for censored bivariate failure time data.Lifetime Data Anal2007https://conductscience.org/library/papers/17221306PubMed
1216188652Amplification and overexpression of CKS1B at chromosome band 1q21 is associated with reduced levels of p27Kip1 and an aggressive clinical course in multiple myeloma.Hematology2005https://conductscience.org/library/papers/16188652PubMed
1331221779The hydroxymethylome of multiple myeloma identifies FAM72D as a 1q21 marker linked to proliferation.Haematologica2020https://conductscience.org/library/papers/31221779PubMed
1424478569The Dantzig Selector for Censored Linear Regression Models.Stat Sin2014https://conductscience.org/library/papers/24478569PubMed
1521484848On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data.Stat Med2011https://conductscience.org/library/papers/21484848PubMed
1610544310Linear regression for bivariate censored data via multiple imputation.Stat Med1999https://conductscience.org/library/papers/10544310PubMed
1729121829Variable selection for accelerated lifetime models with synthesized estimation techniques.Stat Methods Med Res2019https://conductscience.org/library/papers/29121829PubMed
1818573133Regularized estimation for the accelerated failure time model.Biometrics2009https://conductscience.org/library/papers/18573133PubMed
1920037673A group bridge approach for variable selection.Biometrika2009https://conductscience.org/library/papers/20037673PubMed
2016728703The molecular classification of multiple myeloma.Blood2006https://conductscience.org/library/papers/16728703PubMed

See all 29 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35239126

GET https://conductscience.org/api/papers/v1/35239126/references?page=2